Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gomez

Showing results (961-970 of 1,088) with videos related to

Pageof 109
Sort By:
Physical Review Letters|January 31, 2014
Observations of modified three-dimensional instability structure for imploding z-pinch liners that are premagnetized with an axial fieldT J Awe, R D McBride, C A Jennings, et al.
JCO Precision Oncology|January 5, 2023
<i>STK11</i> Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung CancerRohan R Katipally, Liam F Spurr, Stanley I Gutiontov, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2024
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 TrialJay P Reddy, Alexander D Sherry, Bryan Fellman, et al.
The Lancet. Oncology|October 30, 2016
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyDaniel R Gomez, George R Blumenschein, J Jack Lee, et al.
JCO Oncology Practice|May 11, 2022
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series AnalysisNahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, et al.
Lancet (London, England)|December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 studyChiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
Scientific Reports|September 1, 2023
Pathogenic Leptospira are widespread in the urban wildlife of southern CaliforniaSarah K Helman, Amanda F N Tokuyama, Riley O Mummah, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 23, 2020
Changes in Neuroendovascular Procedural Volume During the COVID-19 Pandemic: An International Multicenter StudyAdnan I Qureshi, Samiat Agunbiade, Wei Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation PneumonitisAndreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
American Journal of Respiratory Cell and Molecular Biology|May 27, 2026
Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop reportSeungHye Han, Anny Xiaobo Zhou, Amanda M Jamieson, et al.
Pageof 109

Showing results (961-970 of 1,088) with videos related to

Sort By:
Pageof 109
Physical Review Letters|January 31, 2014
Observations of modified three-dimensional instability structure for imploding z-pinch liners that are premagnetized with an axial fieldT J Awe, R D McBride, C A Jennings, et al.
JCO Precision Oncology|January 5, 2023
<i>STK11</i> Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung CancerRohan R Katipally, Liam F Spurr, Stanley I Gutiontov, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2024
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 TrialJay P Reddy, Alexander D Sherry, Bryan Fellman, et al.
The Lancet. Oncology|October 30, 2016
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyDaniel R Gomez, George R Blumenschein, J Jack Lee, et al.
JCO Oncology Practice|May 11, 2022
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series AnalysisNahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, et al.
Lancet (London, England)|December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 studyChiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
Scientific Reports|September 1, 2023
Pathogenic Leptospira are widespread in the urban wildlife of southern CaliforniaSarah K Helman, Amanda F N Tokuyama, Riley O Mummah, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 23, 2020
Changes in Neuroendovascular Procedural Volume During the COVID-19 Pandemic: An International Multicenter StudyAdnan I Qureshi, Samiat Agunbiade, Wei Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation PneumonitisAndreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
American Journal of Respiratory Cell and Molecular Biology|May 27, 2026
Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop reportSeungHye Han, Anny Xiaobo Zhou, Amanda M Jamieson, et al.
Pageof 109